Addendum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation

Detalles Bibliográficos
Autores principales: Molina-Cerrillo, Javier, Alonso-Gordoa, Teresa, Carrato, Alfredo, Grande, Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2022
Materias:
Addendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671451/
https://www.ncbi.nlm.nih.gov/pubmed/36395352
http://dx.doi.org/10.18632/oncotarget.28312
_version_ 1784832547714236416
author Molina-Cerrillo, Javier
Alonso-Gordoa, Teresa
Carrato, Alfredo
Grande, Enrique
author_facet Molina-Cerrillo, Javier
Alonso-Gordoa, Teresa
Carrato, Alfredo
Grande, Enrique
author_sort Molina-Cerrillo, Javier
collection PubMed
description
format Online
Article
Text
id pubmed-9671451
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-96714512022-11-21 Addendum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation Molina-Cerrillo, Javier Alonso-Gordoa, Teresa Carrato, Alfredo Grande, Enrique Oncotarget Addendum Impact Journals LLC 2022-11-17 /pmc/articles/PMC9671451/ /pubmed/36395352 http://dx.doi.org/10.18632/oncotarget.28312 Text en Copyright: © 2022 Molina-Cerrillo et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Addendum
Molina-Cerrillo, Javier
Alonso-Gordoa, Teresa
Carrato, Alfredo
Grande, Enrique
Addendum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation
title Addendum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation
title_full Addendum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation
title_fullStr Addendum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation
title_full_unstemmed Addendum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation
title_short Addendum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation
title_sort addendum: hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with notch mutation
topic Addendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671451/
https://www.ncbi.nlm.nih.gov/pubmed/36395352
http://dx.doi.org/10.18632/oncotarget.28312
work_keys_str_mv AT molinacerrillojavier addendumhyperprogressiontoadualimmuneblockadefollowedbysubsequentresponsewithcabozantinibinmetastaticpoorriskclearcellrenalcellcarcinomawithnotchmutation
AT alonsogordoateresa addendumhyperprogressiontoadualimmuneblockadefollowedbysubsequentresponsewithcabozantinibinmetastaticpoorriskclearcellrenalcellcarcinomawithnotchmutation
AT carratoalfredo addendumhyperprogressiontoadualimmuneblockadefollowedbysubsequentresponsewithcabozantinibinmetastaticpoorriskclearcellrenalcellcarcinomawithnotchmutation
AT grandeenrique addendumhyperprogressiontoadualimmuneblockadefollowedbysubsequentresponsewithcabozantinibinmetastaticpoorriskclearcellrenalcellcarcinomawithnotchmutation

Ejemplares similares